Protara Therapeutics, Inc.

TARA·NASDAQ·$4.80Share Price as of 11/2·$185MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report06/29/26 8-KCurrent report06/15/26 8-KCurrent report05/13/26 8-KCurrent report03/30/26

Prospectuses and Registrations

S-8Registration of securities for employees08/11/26 424B5Prospectus supplement05/28/26 S-3Shelf registration05/14/26 424B7Prospectus03/06/26 424B7Prospectus02/02/26

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 PRE 14APreliminary proxy04/17/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25

Ownership

SC 13G/ABeneficial ownership (amended)07/07/26 Form 4Insider transaction07/01/26 144Proposed sale of securities06/29/26 Form 4Insider transaction06/16/26 Form 4Insider transaction06/16/26

Other

EFFECTRequest for effectiveness05/22/26 CORRESPCorrespondence with the SEC05/20/26 UPLOADLetter from the SEC05/19/26 ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/25/25